| 摘要 |
The pharmaceutical composition comprises a compound which inhibits the release of mediators of anaphylaxis, such as sodium cromoglycate, in combination with sulphasalazine or an aminosalicylate. The composition of the invention may be used, in particular, for the treatment of gastrointestinal disorders. |
